Comparative Analysis of Adeno-Associated Viral Vector Serotypes 1, 2, 5, 7, And 8 in Mouse Brain

Taymans, Jean-Marc, Vandenberghe, Luk H., Haute, Chris Van Den, Thiry, Irina, Deroose, Christophe M., Mortelmans, Luc, Wilson, James M., Debyser, Zeger +1 more·2007·Human Gene Therapy
DOI 10.1089/hum.2006.178

Cited by (304)

Items 201–300 of 304

  1. Attenuation of Inflammation by DJ-1 May Be a Drug Target for Cerebral Ischemia–Reperfusion Injury
    Na Zhao, Tingting Wang, Peng Li, Yumei Li, Yong Zhao, Shanshan Yu · 2021 · Neurochemical Research
  2. Clearance Pathways for α‐Synuclein in Parkinson's Disease
    Margaret Su-chun Ho · 2025 · Journal of Neurochemistry
  3. Activation of the Ventrolateral Preoptic Neurons Projecting to the Perifornical-Hypothalamic Area Promotes Sleep: DREADD Activation in Wild-Type Rats
    Andrey Kostin, Aftab Alam, Anton Saevskiy, Dennis McGinty, Md. Noor Alam · 2022 · Cells
  4. Transneuronal tracing to map connectivity in injured and transplanted spinal networks
    Tara A. Fortino, Margo L. Randelman, Adam A. Hall, Jasbir Singh, David C. Bloom, Esteban A. Engel, Daniel J. Hoh, Shaoping Hou, Lyandysha V. Zholudeva, Michael Aron Lane · 2022 · Experimental Neurology
  5. Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration
    Anandh Dhanushkodi, Yi Xue, Emily E. Roguski, Yun Ding, Shannon G. Matta, Detlef H. Heck, Guo-Huang Fan, Michael P. McDonald · 2018 · Neuroscience Letters
  6. Sex‐specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice
    Zhenhua Jiang, Qun Wang, Jianshuai Zhao, Jiajia Wang, You Li, Wei Dai, Xiao Zhang, Zongping Fang, Wugang Hou, Lize Xiong · 2022 · The Journal of Comparative Neurology
  7. Current trends in gene therapy to treat inherited disorders of the brain
    Żaneta Matuszek, Brandon L. Brown, Carolyn M. Yrigollen, Megan S. Keiser, Beverly L. Davidson · 2025 · Molecular Therapy
  8. Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy
    Dennison Trinh, Ahmad R. Israwi, Harsimar Brar, Jose E.A. Villafuerte, Ruella Laylo, Humaiyra Patel, Sabika Jafri, Lina Al Halabi, Shaumia Sinnathurai, Kiran Reehal et al. · 2023 · Neurobiology of Disease
  9. A brief guide for gene delivery to the brain using adeno-associated viral vectors
    Seungwan Han, Eun Mo Yang, Eun‐Mi Hur · 2025 · Molecules and Cells
  10. Personalised Medicine: Genome Maintenance Lessons Learned from Studies in Yeast as a Model Organism
    Arwa A. Abugable, Dahlia A. Awwad, Dalia Fleifel, Mohamed Medhat Ali, Sherif F. El‐Khamisy, Menattallah Elserafy · 2017 · Advances in experimental medicine and biology
  11. Dissecting inhibitory brain circuits with genetically-targeted technologies
    Dona K. Murphey, Alexander M. Herman, Benjamin Russell Arenkiel · 2014 · Frontiers in Neural Circuits
  12. Optogenetic Control of Neural Circuits in the Mongolian Gerbil
    Stefan Keplinger, Barbara Beiderbeck, Stylianos Michalakis, Martin Biel, Benedikt Grothe, Lars Kunz · 2018 · Frontiers in Cellular Neuroscience
  13. Comparison of AAV Serotypes for Gene Delivery to Dopaminergic Neurons in the Substantia Nigra
    Joanna A. Korecka, Marijn Schouten, Ruben Eggers, Ayşe Ulusoy, Koen Bossers, Joost Verhaage · 2011 · InTech eBooks
  14. An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-κB Activation for Disease-Inducible Gene Transfer
    Abdelwahed Chtarto, Olivier Bockstael, Elias Gebara, Katia Vermoesen, Catherine Melas, Catherine Pythoud, Marc Levivier, Olivier De Witte, Ruth Luthi‐Carter, Ralph Clinkers et al. · 2013 · PLoS ONE
  15. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders
    Bharat Bhushan, Kuldeep Singh, Shivendra Kumar, Anjali Bhardwaj · 2024 · Current Gene Therapy
  16. Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway
    Seong‐Jin Yu, Mikko Airavaara, Hui Shen, Jenny Chou, Brandon K. Harvey, Yun Wang · 2011 · Psychopharmacology
  17. Genetic targeting of specific neuronal cell types in the cerebral cortex
    Alan Urban, Jean Rossier · 2012 · Progress in brain research
  18. Adeno-associated virus type 2 vectors: transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1
    Lalitha R. Belur, William F. Kaemmerer, R. Scott McIvor, Walter C. Low · 2008 · Archives of Virology
  19. Adeno-associated viral serotypes differentially transduce inhibitory neurons within the rat amygdala
    Christopher A. de Solis, Matthew P. Hosek, Roopashri Holehonnur, A. Ho, Anwesha Banerjee, Jonathan A. Luong, Lauren E. Jones, Dushyant Chaturvedi, Jonathan E. Ploski · 2017 · Brain Research
  20. Immune-Directed Gene Therapeutic Development for Alzheimer’s, Prion, and Parkinson’s Diseases
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2008 · Journal of Neuroimmune Pharmacology
  21. Disease Modification Through Trophic Factor Delivery
    Mari H. Savolainen, Dwaine F. Emerich, Jeffrey H. Kordower · 2018 · Methods in molecular biology
  22. Comparative Analysis of Six Adeno-Associated Viral Vector Serotypes in Mouse Inferior Colliculus and Cerebellum
    Isabelle F. Witteveen, Timothy S. Balmer · 2024 · eNeuro
  23. Cell Type‐Specific mTORC1 Signaling and Translational Control in Synaptic Plasticity and Memory
    Ziying Huang, Niaz Mahmood, Shane A. Wiebe, Arkady Khoutorsky, Jean‐Claude Lacaille, Nahum Sonenberg · 2025 · Journal of Neurochemistry
  24. Glial Cell Line-Derived Neurotrophic Factor Partially Ameliorates Motor Symptoms without Slowing Neurodegeneration in Mice with Respiratory Chain-Deficient Dopamine Neurons
    Fredrik H. Sterky, Karin Pernold, Brandon K. Harvey, Eva Lindqvist, Barry J. Hoffer, Lars Olson · 2012 · Cell Transplantation
  25. Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression
    Benjamin William Schlichtmann, Bharathi N. Palanisamy, Emir Malovic, Susheel K. Nethi, Piyush Padhi, Monica Hepker, Joseph Wurtz, Manohar John, Bhupal Ban, Vellareddy Anantharam et al. · 2023 · Biomolecules
  26. Adeno-Associated Viral Vectors in the Treatment of Epilepsy
    Aysilu I. Mullagulova, Тимечко Елена Евгеньевна, Valeriya V. Solovyeva, Alexey M. Yakimov, Ahmad Ibrahim, Д. В. Дмитренко, Albert Akramovich Sufianov, Г. З. Суфианова, Albert Anatolyevich Rizvanov · 2024 · International Journal of Molecular Sciences
  27. Molecular neurosurgery: vectors and vector delivery strategies
    Edward White · 2012 · British Journal of Neurosurgery
  28. Recombinant adeno-associated virus-based gene therapy combined with tissue engineering for musculoskeletal regenerative medicine.
    Yiqing Wang, Xiangyu Chu, Bing Wang · 2021 · PubMed Central
  29. Transduction characteristics of alternative adeno-associated virus serotypes in the cat brain by intracisternal delivery
    Jacqueline E. Hunter, Caitlyn M. Molony, Jessica H. Bagel, Patricia A. O’Donnell, Stephen G. Kaler, John H N Wolfe · 2022 · Molecular Therapy — Methods & Clinical Development
  30. The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency
    Ryota Nakahama, Aika Saito, Sensho Nobe, Kazuya Togashi, Ikuo Suzuki, Akira Uematsu, Kazuo Emoto · 2022 · Molecular Brain
  31. Repairing the Brain: Gene Therapy
    Tomas Björklund · 2018 · Journal of Parkinson s Disease
  32. Selective targeting of striatal parvalbumin-expressing interneurons for transgene delivery
    Marcelo Duarte Azevedo, Sibilla Sander, Cheryl Jeanneret, Soophie Olfat, Liliane Tenenbaum · 2021 · Journal of Neuroscience Methods
  33. Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71
    Betty W. Wu, Michael B. Yee, Ronald S. Goldstein, Paul R. Kinchington · 2022 · Viruses
  34. Long-Range, Border-Crossing, Horizontal Axon Radiations Are a Common Feature of Rat Neocortical Regions That Differ in Cytoarchitecture
    Brett A. Johnson, Ron D. Frostig · 2018 · Frontiers in Neuroanatomy
  35. Deep Brain Stimulation of the Medial Septal Nucleus Induces Expression of a Virally Delivered Reporter Gene in Dentate Gyrus
    Anton Fomenko, Darrin J. Lee, Chris McKinnon, Eun Jung Lee, Mitchell L. de Snoo, Elise Gondard, Clemens Neudorfer, Clement Hamani, Andrés M. Lozano, Lorraine V. Kalia et al. · 2020 · Frontiers in Neuroscience
  36. Viral vectors for gene delivery to the central nervous system
    Selene Ingusci, Bonnie L. Hall, William F. Goins, Justus B. Cohen, Joseph C. Glorioso · 2024 · Handbook of clinical neurology
  37. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy
    Umut Cagin · 2021 · Advances in experimental medicine and biology
  38. Dose-response relationship between the variables of unilateral optogenetic stimulation and transcallosal evoked responses in rat motor cortex
    Christian Stald Skoven, Leo Tomasevic, Duda Kvitsiani, Bente Pakkenberg, Tim B. Dyrby, Hartwig Roman Siebner · 2022 · Frontiers in Neuroscience
  39. Photonics meets connectomics: case of diffuse, long-range horizontal projections in rat cortex
    Brett A. Johnson, Ron D. Frostig · 2015 · Neurophotonics
  40. Consideration of gene therapy for paediatric neurotransmitter diseases
    Michael S. Rotstein, Un Jung Kang · 2009 · Journal of Inherited Metabolic Disease
  41. The Use of an Adeno-Associated Viral Vector for Efficient Bicistronic Expression of Two Genes in the Central Nervous System
    Thomas Haynes Hutson, Claudia Kathe, Sean Christopher Menezes, Marie-Claire Rooney, Hansruedi Büeler, Lawrence David Falcon Moon · 2014 · Methods in molecular biology
  42. New therapeutic strategies for the treatment of metachromatic leukodystrophy
    Alisa A. Shaimardanova, Daria S. Chulpanova, Valeriya V. Solovyeva, Aysilu I. Mullagulova, Kristina Viktorovna Kitaeva, Albert Anatolyevich Rizvanov · 2020 · Genes and Cells
  43. Local Knockdown of ERK2 in the Adult Mouse Brain Via Adeno-Associated Virus-Mediated RNA Interference
    Barbara Di Benedetto, Benedikt Wefers, Wolfgang Wurst, Ralf Kühn · 2008 · Molecular Biotechnology
  44. Gene Therapy Methods and Their Applications in Neurological Disorders
    Mingjie Li, B. Joy Snider · 2018 · Elsevier eBooks
  45. Gene therapy using AAV vectors
    Keiya Ozawa · 2007 · Drug Delivery System
  46. Using Recombinant Adeno-Associated Viral Vectors for Gene Expression in the Brain
    Anke Van der Perren, Jaan Toelen, Jean‐Marc Taymans, Veerle Baekelandt · 2011 · Neuromethods
  47. Gene Therapy Targeting GD3 Synthase Protects Against MPTP‐Induced Parkinsonism and Executive Dysfunction
    Panchanan Maiti, Yi Xue, Tonia S. Rex, Michael P. McDonald · 2025 · European Journal of Neuroscience
  48. A comparison of the impact on neuronal transcriptome and cognition of rAAV5 transduction with three different doses in the mouse hippocampus
    Yi-Si Liu, Mengling Wang, Neng-Yuan Hu, Ziming Li, Jiali Wu, Hao Li, Jingting Li, Xiaowen Li, Jian‐Ming Yang, Tianming Gao et al. · 2023 · Frontiers in Molecular Neuroscience
  49. Gene therapy using AAV
    Keiya Ozawa · 2007 · Uirusu
  50. Safety of Adeno-Associated Viral Vectors
    Shih‐Wen Lin, Hildegund C.J. Ertl · 2008 · Future Virology
  51. Disease-specific interventions: The use of cell and gene therapies for Parkinson disease
    Roger A. Barker, Philip C. Buttery · 2024 · Handbook of clinical neurology
  52. Adeno-Associated Virus Gene Therapy and Its Application to the Prevention and Personalised Treatment of Rare Diseases
    Konstantina Grosios, Harald Petry, Jacek Lubelski · 2014 · Advances in predictive, preventive and personalised medicine
  53. Viral Vectors in Primate Research: Examples from Parkinson’s Disease Research
    Grégory Porras, Benjamin Dehay, Erwan Bézard · 2013 · Neuromethods
  54. Viral vectors for gene delivery
    Katharine J. Liang, Richard Jude Samulski · 2015
  55. Gene Therapy for Parkinson’s Disease: Towards Non Invasive Approaches
    Manuel Rodrı́guez, Jose M., Rafael Castro · 2011 · InTech eBooks
  56. Multifunctional Nanoscale Delivery Systems for Nucleic Acids
    Richard Conroy, Belinda Seto · 2013 · Springer eBooks
  57. Gene Therapy for Spinal Cord Injury
    Ioana Goganau, Armin Blesch · 2016 · Springer eBooks
  58. Integrated Optogenetic and Electrophysiological Dissection of Local Cortical Circuits In Vivo
    Jessica A. Cardin · 2011 · Neuromethods
  59. Application to Gene Therapy and Vaccination
    Lei Su, William J. Bowers, Michelle C. Janelsins, Howard J. Federoff · 2016 · Springer eBooks
  60. Promotion of regeneration in the injured nervous system
    Michael E. Selzer, Stéphanie Clarke, Leonardo G. Cohen, Gert Kwakkel, Robert H. Miller · 2014 · Cambridge University Press eBooks
  61. Advances in Gene Delivery Methods to Label and Modulate Activity of Upper Motor Neurons: Implications for Amyotrophic Lateral Sclerosis
    Mouna Haidar, Aida Viden, Bradley J. Turner · 2021 · Brain Sciences
  62. Serotypy wirusów związanych z adenowirusami
    Agnieszka Lipiec, Maciej Małecki, Karolina Hajdukiewicz · 2009 · Postępy Biochemii
  63. Viral‐Mediated Delivery of shRNA and miRNA
    Fredric P. Manfredsson · 2013 · Wiley eBooks
  64. Silencing Huntington’s Disease Gene with RNAi
    Yu Zhang, Robert Max Friedlander · 2010 · RNA technologies
  65. Delivery Strategies for RNAi to the Nervous System
    Kevin D. Foust, Brian K. Kaspar · 2011 · Neuromethods
  66. Combinations of gene therapy, tissue transplantation and pharmacotherapeutic techniques in visual system repair
    Mats Hellström · 2010 · UWA Profiles and Research Repository (UWA)
  67. Top-down attention: neural pathways in the human and non-human primate examined by electrophysiology, optogenetics and psychophysics
    Janina Hüer · 2019
  68. Trophic factor delivery by gene therapy
    Christopher Trimby, George M. Smith · 2014 · Cambridge University Press eBooks
  69. The Study of Two Strategies for Decreasing Mutant Huntingtin: Degradation by Puromycin Sensitive AminoPeptidase and RNA Interference: A Dissertation
    Joanna Chaurette · 2013
  70. Recombinant AAV gene therapy and delivery for Alzheimer's disease
    Nikisha Carty · 2009
  71. Developing RNAi therapy For DYT1 dystonia
    J. N. Martin, Pedro Gonzalez‐Alegre, Daniel J. Bonthius, Beverly L. Davidson, Anton P. McCaffrey, Richard J. Smith · 2011
  72. A newly designed AAV-rDNA vector for persistent therapy in genetic liver diseases
    Zhongya Wang · 2015
  73. Novel biosensors for preclinical brain tumor analysis
    Johanna M. Niers · 2011 · Pure Amsterdam UMC
  74. Molecular imaging of lentiviral vector-mediated reporter gene expression with positron emission tomography and bioluminescence imaging
    Christophe M. Deroose · 2007
  75. Engineered adeno associated-viruses expressing anti-prp molecules and polyelectrolyte gold nanoparticles as new therapeutic strategies for prion diseases in mouse models
    Fabio Moda · 2010 · BOA (University of Milano-Bicocca)
  76. Selektiver Gentransfer in Rattenherzen Transduktion mittels AAV-2 im heterotopen abdominellen Transplantationsmodell
    Lars Burdorf · 2008
  77. Applications of CRISPR-Cas systems in neuroscience
    Cambridge Harvard · 2016
  78. COUPLING VOLTAMMETRY WITH OPTOGENETICS TO REVEAL AXONAL CONTROL OF DOPAMINE TRANSMISSION BY STRIATAL ACETYLCHOLINE
    Polina Kosillo, Katherine R. Brimblecombe, Sarah Threlfell, Stephanie Jane Cragg · 2014 · WORLD SCIENTIFIC eBooks
  79. AAV-based gene therapy for axonal regeneration in a rat model of rubrospinal tract lesion
    Malleswari Challagundla · 2015
  80. Characterization of the CAG 140 Mouse Model of Huntington's Disease and the Effects of rAAV Delivered shRNA and hGFP
    Aaron C. Rising · 2010
  81. AAV-Nrf2 Mediated Rescue of Oxidative Stress in Mouse Models
    Katharine J. Liang · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  82. DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER
    Blake H. Albright · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  83. CREB Induces Structural Changes in LA Neurons making them more Advantageous for Inclusion into the Fear Memory Trace
    Gemma V. Higgs · 2013 · TSpace (University of Toronto)
  84. Faculty Opinions recommendation of Functional identification of an aggression locus in the mouse hypothalamus.
    Michael Ehlers · 2011 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  85. Peer Review #1 of "Evaluation of AAV-DJ vector for retinal gene therapy (v0.1)"
    2019 · PeerJ
  86. Peer Review #2 of "Evaluation of AAV-DJ vector for retinal gene therapy (v0.2)"
    2019 · PeerJ
  87. Faculty Opinions recommendation of Development of an optogenetic toolkit for neural circuit dissection in squirrel monkeys.
    John F. Kalaska · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  88. Peer Review #2 of "Evaluation of AAV-DJ vector for retinal gene therapy (v0.1)"
    2019 · PeerJ
  89. Peer Review #1 of "Evaluation of AAV-DJ vector for retinal gene therapy (v0.2)"
    2019 · PeerJ
  90. Novel Theranostics for Parkinson's Disease
    Benjamin William Schlichtmann · 2021
  91. Inner-ear delivery of AAV2-retro robustly labels lateral olivocochlear efferents but results in off-target transfection in the contralateral cochlea and the brain
    Mahmoud Khalil, Mikayla Bisignani, Karl Kandler · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Additional file 1 of The tyrosine capsid mutations on retrograde adeno-associated virus accelerates gene transduction efficiency
    Ryota Nakahama, Aika Saito, Sensho Nobe, Kazuya Togashi, Ikuo Suzuki, Akira Uematsu, Kazuo Emoto · 2022 · Figshare
  93. Thought-provoking advances in virus-mediated targeted gene therapies: pseudotyping and tissue-specific transcription
    Mardmohammad Davoudi, Touraj Farazmandfar · 2026 · Future Virology
  94. Etude de thérapies génique et pharmacologique visant à restaurer les capacités cognitives d’un modèle murin de la Dystrophie musculaire de Duchenne
    Caroline Perronnet · 2011 · theses.fr (ABES)
  95. Traitement des informations thalamiques au travers des ganglions de la base : approche électrophysiologique et optogénétique in vivo
    Maroua Hanini‐Daoud · 2016
  96. Imaging of cAMP/PKA dynamics induced by catecholamines in the neocortical network
    Shinobu Nomura · 2014 · theses.fr (ABES)
  97. Recombinant Adeno-Associated Viruses : process development and gene transfer application for muscular dystrophy
    Gabriella Dias Florencio Leite · 2017
  98. When engineering new recombinant factor IX molecules meets gene therapy : improvement of factor IX plasma level in patients with haemophilia B?
    Sandra Le Quellec · 2018 · theses.fr (ABES)
  99. Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research community
    Joaquín Pardo, Janitha M. Mudannayake, Luis Daniel Bernal-Conde, Ivette M. Sandoval, Ryan B. Dong, Martino Avallone, David J. Marmion, Addison R Gralen, Lauren Waite, Andreas Heuer et al. · 2026 · Journal of Parkinson s Disease
  100. Deciphering nervous systems wiring: Tract-tracing and complementary methods
    Oliver Schmitt, Peter Eipert, Rafael Tappe Maestro, Marie Bellmann, Stefanie Haase, Paulina Morawska, Vishnu Prathapan · 2026 · Neuroscience & Biobehavioral Reviews